Effect of laser Therapy in Tempromandibular Joint Disorders

The Efficacy of 940 nm Low-level Laser Therapy on Treatment of Patients with Myogenic Tempromandibular Joint Disorders

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180224038840N4

Enrollment

Registered

2022-05-06

Start date

2022-04-21

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tempromandibular Joint disorders. Tempromandibular Joint disorders

Interventions

Intervention 1: Intervention group: Intervention group: In the intervention group, 940 nm laser by Epic X biolase laser device (Ezlase

Biolase Technology, Inc., Irvine, CA, USA) will be used after review and calibration by the manufacturer, in the light and laser clinic, with output power of 300 mW in continuous mode, under dedicated

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: limited mouth opening or functionpresence of pain in masticatory muscles and/or TMJs, either in clenching or in jaw movements (TMD muscular disturbance (class Ia, Ib) or arthralgia (class IIIa).

Exclusion criteria

Exclusion criteria: patients who had major systemic disorders patients who received analgesic or anti-depressant over the last 2 weeks patients who had any bony abnormalities of the jaws such as arthropathy of the TMJ or rheumatoid arthritis Patients with psychological illness Patients with arthralgic temporomandibular joint disorders patients who received any form of treatment for TMD within the last month pregnant and feeding patients

Design outcomes

Primary

Measure	Time frame
The number of pain intensity on visual analogue scale (VAS). Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: visual analogue scale (VAS).	—

Secondary

Measure	Time frame
Amount of mouth opening. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Digital ruler.;The amount of deviation while opening the mouth. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: observation.;Satisfaction with treatment. Timepoint: In the last session of laser treatment. Method of measurement: questionnaire.;Click sound. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Hearing.	—

Measure

Time frame

Amount of mouth opening. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Digital ruler.;The amount of deviation while opening the mouth. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: observation.;Satisfaction with treatment. Timepoint: In the last session of laser treatment. Method of measurement: questionnaire.;Click sound. Timepoint: Measurement of pain intensity before the intervention, 2 weeks and 4 weeks after the start of the intervention and 1 month after the end of the treatment sessions. Method of measurement: Hearing.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra hajizadeh

Oroumia University of Medical Sciences

zahrahajizadeee19@gmail.com+98 44 3336 3600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026